Genetic factors in the development of pituitary adenomas

Endocrine Development

Volumn 17, Issue , 2009, Pages 121-133

  Vandeva, Silvia ^a   Tichomirowa, Maria A ^a   Zacharieva, Sabina ^a   Daly, Adrian F ^a   Beckers, Albert ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CYCLIN A; CYCLIN D; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN E; DOPAMINE RECEPTOR STIMULATING AGENT; FIBROBLAST GROWTH FACTOR RECEPTOR 2; LIGAND; OCTREOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C;

ALBRIGHT SYNDROME; CARCINOGENESIS; CARNEY COMPLEX; CELL CYCLE; CHROMOSOMAL INSTABILITY; COMPRESSION; FAMILIAL ISOLATED PITUITARY ADENOMA; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; GENOTYPE; GROWTH HORMONE SECRETING ADENOMA; HEREDITY; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; INTRACRANIAL TUMOR; INTROSPECTION; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOMA; CARNEY COMPLEX; CELL CYCLE PROTEINS; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PITUITARY NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84925867392     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000262534     Document Type: Review

References (41)

1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE: The prevalence of pituitary adenomas: a systematic review. Cancer 2004;101:613-619.
2. Davis JR, Farrell WE, Clayton RN: Pituitary tumours. Reproduction 2001;121:363-371.
3. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A: High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006;91:4769-4775.
4. Melmed S: Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 2003;112:1603-1618.
5. Daly AF, Jaffrain-Rea ML, Ciccarelli A, et al: Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 2006;91:3316-3323.
6. Levine MA: Clinical implications of genetic defects in G proteins: oncogenic mutations in G alpha s as the molecular basis for the McCune-Albright syndrome. Arch Med Res 1999;30:522-531.
7. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA: Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006;312: 1228-1230.
8. Daly AF, Vanbellinghen JF, Khoo SK, et al: Aryl hydrocarbon receptor interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 2007;92: 1891-1896.
9. Horvath A, Stratakis CA: Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors. Rev Endocr Metab Disord 2008;9:1-11.
10. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, et al: Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 2006;103:15558-15563.
11. Georgitsi M, Raitila A, Karhu A, et al: Germline CDKN1B/p27kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 2007;92:3321-3325.
12. Kirschner LS, Carney JA, Pack SD, et al: Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.
13. Heaney AP: Pituitary tumour pathogenesis. Br Med Bull 2006;75-76:81-97.
14. Beckers A, Daly A: The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 2007;157:371-382.
15. Verloes A, Stevenaert A, Teh BT, Petrossians P, Beckers A: Familial acromegaly: case report and review of the literature. Pituitary 1999;1:273-277.
16. Valdes-Socin H, Poncin J, Stevens V, Stevenaert A, Beckers A: Adenomes hypophysaires familiaux isoles non lies avec la mutation somatique NEM-1: suivi de 27 patients. Ann Endocrinol 2000;61:301.
17. Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A: Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002; 87:457-465.
18. Luccio-Camelo DC, Une KN, Ferreira RE, Khoo SK, Nickolov R, Bronstein MD, Vaisman M, Teh BT, Frohman LA, Mendonca BB, Gadelha MR: A meiotic recombination in a new isolated familial somatotropinoma kindred. Eur J Endocrinol 2004;150: 643-648.
19. Daly AF, Tichomirowa MA, Beckers A: Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma. Horm Res 2009;71(suppl 1):105-111.
20. Carver LA, Bradfield CA: Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 1997; 272:11452-11456.
21. Georgitsi M, Karhu A, Winqvist R, Visakorpi T, Waltering K, Vahteristo P, Launonen V, Aaltonen LA: Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. Br J Cancer 2007;96:352-356.
22. Huang G, Elferink CJ: Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Mol Pharmacol 2005;67:88-96.
23. Chandrasekharappa SC, Guru SC, Manickam P, et al: Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-407.
24. La P, Desmond A, Hou Z, Silva AC, Schnepp RW, Hua X: Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression. Oncogene 2006;25:3537-3546.
25. Lemos MC, Thakker RV: Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008;29:22-32.
26. Kirschner LS, Carney JA, Pack SD, et al: Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.
27. Stratakis CA, Carney JA, Lin JP, et al: Carney complex, a familial multiple neoplasia and lentiginosis syndrome: analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996; 97:699-705.
28. Boikos SA, Stratakis CA: Carney complex: the first years. Curr Opin Oncol 2007;19:24-29.
29. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989;340:692-696.
30. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A: The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 2002;87:4736-4740.
31. Riminucci M, Collins MT, Lala R, et al: An R201H activating mutation of the GNAS1 (Gsalpha) gene in a corticotroph pituitary adenoma. Mol Pathol 2002;55:58-60.
32. Boikos SA, Stratakis CA: Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorogenesis. Hum Mol Genet 2007;16:R80-R87.
33. Lin Y, Jiang X, Shen Y, Li M, Ma H, Xing M, Lu Y: Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors. Endocr Relat Cancer 2009;16:301-310.
34. Hibberts NA, Simpson DJ, Bicknell JE, et al: Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic pituitary tumors. Clin Cancer Res 1999;5:2133-2139.
35. Quereda V, Malumbres M: Cell cycle control of pituitary development and disease. J Mol Endocrinol 2009;42:75-86.
36. Zhang X, Sun H, Danila DC, et al: Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 2002;87:1262-1267.
37. Pagotto U, Arzberger T, Theodoropoulou M, et al: The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas. Cancer Res 2000;60:6794-6799.
38. Valleley EM, Cordery SF, Bonthron DT: Tissuespecific imprinting of the ZAC/PALGL 1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters. Hum Mol Genet. 2007;16:972-981.
39. Ezzat S: Epigenetic control in pituitary tumors. Endocr J 2008;55:951-957.
40. Yu R, Melmed S: Pituitary tumor transforming gene: an update. Front Horm Res 2004;32:175-185.
41. Gejman R, Batista SL, Zhong Y, Zhou Y, Zhang X, Swearingen B, Stratakis CA, Hedley-Whyte ET, Klibanski A: Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically non-functioning pituitary adenomas. J Clin Endocrinol Metab 2008;93:4119-4125.